Stanozolol in treatment of leg ulcers due to cryofibrinogenaemia

V. Falanga, R. S. Kirsner, W. H. Eaglstein, M. H. Katz, F. A. Kerdel

Research output: Contribution to journalArticle

53 Scopus citations

Abstract

Five consecutive patients with cryofibrinogenaemia in association with painful leg ulcers and intravascular dermal thrombi were treated with stanozolol, an androgenic steroid with fibrinolytic properties. In all patients treatment was followed by rapid and striking pain relief and healing of the ulcers. Cryofibrinogenaemia was not detected on subsequent laboratory evaluation, and dermal intravascular thrombi had resolved on repeat histological examination.

Original languageEnglish (US)
Pages (from-to)347-348
Number of pages2
JournalThe Lancet
Volume338
Issue number8763
DOIs
StatePublished - Aug 10 1991

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint Dive into the research topics of 'Stanozolol in treatment of leg ulcers due to cryofibrinogenaemia'. Together they form a unique fingerprint.

  • Cite this

    Falanga, V., Kirsner, R. S., Eaglstein, W. H., Katz, M. H., & Kerdel, F. A. (1991). Stanozolol in treatment of leg ulcers due to cryofibrinogenaemia. The Lancet, 338(8763), 347-348. https://doi.org/10.1016/0140-6736(91)90483-6